Kong Garheng (CIK 1435183) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-05). Recent activity: Buy XERS (24,193 shares), Buy LH (897 shares), Buy XERS (50,000 shares), Buy LH (944 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 24,193 | $0 |
| 2026-02-13 | LABCORP HOLDINGS INC. (LH) | Director | Buy | 897 | $0 |
| 2025-06-04 | Xeris Biopharma Holdings, Inc. (XERS) | Director | Buy | 50,000 | $0 |
| 2025-02-10 | LABCORP HOLDINGS INC. (LH) | Director | Buy | 944 | $0 |
Source: SEC Form 4 filings · as of 2026-06-05